Related references
Note: Only part of the references are listed.Dynamic prediction model and risk assessment chart for cardiovascular disease based on on-treatment blood pressure and baseline risk factors
Satoshi Teramukai et al.
HYPERTENSION RESEARCH (2016)
A sodium-glucose co-transporter 2 inhibitor empagliflozin prevents abnormality of circadian rhythm of blood pressure in salt-treated obese rats
Yui Takeshige et al.
HYPERTENSION RESEARCH (2016)
The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy
Atsuhisa Sato
HYPERTENSION RESEARCH (2015)
Morning hypertension and night non-dipping in patients with diabetes and chronic kidney disease
Se Won Oh et al.
HYPERTENSION RESEARCH (2015)
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension
Ilkka Tikkanen et al.
DIABETES CARE (2015)
Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes
Takashi Wada et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2014)
Preface: evidence-based clinical practice guidelines for CKD-an abridged English version
Kenjiro Kimura
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2014)
Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study
Kazuaki Shimamoto et al.
HYPERTENSION RESEARCH (2014)
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
Vlado Perkovic et al.
KIDNEY INTERNATIONAL (2013)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
P. L. Drury et al.
DIABETOLOGIA (2011)
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials
Frank A. Holtkamp et al.
EUROPEAN HEART JOURNAL (2011)
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
Remy Boussageon et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Sodium Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes Mellitus
Sunil Nair et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Night Time Blood Pressure Variability Is a Strong Predictor for Cardiovascular Events in Patients With Type 2 Diabetes
Kazuo Eguchi et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Identification of an Increased Short-Term Blood Pressure Variability on Ambulatory Blood Pressure Monitoring as a Coronary Risk Factor in Diabetic Hypertensives
Motoko Ozawa et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2009)
Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
Toshiharu Ninomiya et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Ambulatory blood pressure and heart rate in hypertensives with renal failure: Comparison between diabetic nephropathy and non-diabetic glomerulopathy
Kouichi Tamura et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2008)
Effect of a multifactorial intervention on mortality in type 2 diabetes
Peter Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study
Anne Sofie Astrup et al.
JOURNAL OF HYPERTENSION (2007)
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
AI Adler et al.
KIDNEY INTERNATIONAL (2003)
Share Paper
